Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Dopaminergic and serotonergic ligands in development at Sanofi-Synthelabo

May 27, 1999

Antalarmin suppresses stress-related behavior in nonhuman primate model

May 27, 1999

Cephalon's narcolepsy treatment available in Austria

May 27, 1999

CoCensys and Parke-Davis collaboration yields development compound

May 27, 1999

Fluvoxamine maleate launched in Japan for social anxiety disorder

May 26, 1999

Yoshitomi discloses new antipsychotics in recent patent literature

May 26, 1999

Ortho-McNeil describes new dipyridoimidazole series of GABA-A receptor ligands

May 26, 1999

NeuroSearch-Meiji Seika team discovers positive modulators of GABA-A receptor complex

May 26, 1999

Cortex receives SBIR grant for new stroke therapy

May 25, 1999

Tetrahydrofurans as 5-HT2 receptor antagonists: synthesis and preliminary pharmacological evaluation

May 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...